|
1
|
El-Serag HB: Epidemiology of viral
hepatitis B-related hepatocellular carcinoma. Gastroenterology.
142:1264–1273. 2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zoulim F, Liang TJ, Gerbes AL, Aghemo A,
Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK,
Terrault NA and Wiktor S: Hepatitis C virus treatment in the real
world: Optimising treatment and access to therapies. Gut.
64:1824–1833. 2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Nahon P, Bourcier V, Layese R, Audureau E,
Cagnot C, Marcellin P, Guyader D, Fontaine H, Larrey D, Lédinghen
VD, et al: Eradication of hepatitis C virus infection in patients
with cirrhosis reduces risk of liver and non-liver complications.
Gastroenterology. 152:142–156.e2. 2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Lockart I, Yeo MGH, Hajarizadeh B, Dore GJ
and Danta M: HCC incidence after hepatitis C cure among patients
with advanced fibrosis or cirrhosis: A meta-analysis. Heptology.
76:139–154. 2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cacoub P, Comarmond C, Domont F, Savey L,
Desbois AC and Saadoun D: Extrahepatic manifestations of chronic
hepatitis C virus infection. Ther Adv Infect Dis. 3:3–14.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ioannou GN and Feld JJ: What are the
benefits of a sustained virologic response to direct-acting
antiviral therapy for hepatitis C virus infection?
Gastroenterology. 156:446–460.e2. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Takahashi H, Nakahara T, Kogiso T, Imajo
K, Kessoku T, Kawaguchi T, Ide T, Kawanaka M, Hyogo H, Fujii H, et
al: Eradication of hepatitis C virus with direct-acting antivirals
improves glycemic control in diabetes: A multicenter study. JGH
Open. 5:228–234. 2021.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ichikawa T, Miyaaki H, Miuma S, Taura N,
Motoyoshi Y, Akahoshi H, Nakamura S, Nakamura J, Takahashi Y, Honda
T, et al: Hepatitis C virus-related symptoms, but not quality of
life, were improved by treatment with direct-acting antivirals.
Hepatol Res. 48:E232–E239. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi
Y, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T, Yajima H,
et al: Direct-acting antivirals improved the quality of life,
ameliorated disease-related symptoms, and augmented muscle volume
three years later in patients with hepatitis C virus. Intern Med.
59:2653–2660. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sugimoto R, Iwasa M, Hara N, Tamai Y,
Yoshikawa K, Ogura S, Tanaka H, Eguchi A, Yamamoto N, Kobayashi Y,
et al: Changes in liver function and body composition by
direct-acting antiviral therapy for hepatitis C virus infection.
Hepatol Res. 48:337–344. 2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Arase Y, Suzuki F, Suzuki Y, Akuta N,
Kobayashi M, Sezaki H, Hosaka T, Kawamura Y, Yatsuji H, Hirakawa M,
et al: Virus clearance reduces bone fracture in postmenopausal
women with osteoporosis and chronic liver disease caused by
hepatitis C virus. J Med Virol. 82:390–395. 2010.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Hofmann WP, Kronenberger B, Bojunga J,
Stamm B, Herrmann E, Bücker A, Mihm U, von Wagner M, Zeuzem S and
Sarrazin C: Prospective study of bone mineral density and
metabolism in patients with chronic hepatitis C during pegylated
interferon α and ribavirin therapy. J Viral Hepat. 15:790–796.
2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Rouillard S and Lane NE: Hepatic
osteodystrophy. Hepatology. 33:301–307. 2001.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ehnert S, Aspera-Werz RH, Ruoß M, Dooley
S, Hengstler JG, Nadalin S, Relja B, Badke A and Nussler AK:
Hepatic osteodystrophy-molecular mechanisms proposed to favor its
development. Int J Mol Sci. 20(2555)2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Leslie WD, Bernstein CN and Leboff MS:
American Gastroenterological Association Clinical Practice
Commitee. AGA technical review on osteoporosis in hepatic
disorders. Gastroenterology. 125:941–966. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Chen CH, Lin CL and Kao CH: Relation
between hepatitis C virus exposure and risk of osteoporosis: A
nationwide population-based study. Medicine (Baltimore).
94(e2086)2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lai JC, Shoback DM, Zipperstein J, Lizaola
B, Tseng S and Terrault NA: Bone mineral density, bone turnover,
and systemic inflammation in non-cirrhotics with chronic hepatitis
C. Dig Dis Sci. 60:1813–1819. 2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Olmos-Martínez JM, Hernández JL, Fábrega
E, Olmos JM, Crespo J and González-Macías J: Bone mineral density
and trabecular bone score in treatment-naïve patients with
non-cirrhotic hepatitis C virus infection. Arch Osteoporos.
15(72)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sultana H, Komai M and Shirakawa H: The
role of vitamin K in cholestatic liver disease. Nutrients.
13(2515)2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Tanaka N, Arima K, Nishimura T, Tomita Y,
Mizukami S, Okabe T, Abe Y, Kawashiri SY, Uchiyama M, Honda Y, et
al: Vitamin K deficiency, evaluated with higher serum ucOC, was
correlated with poor bone status in women. J Physiol Anthropol.
39(9)2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Miller PD, Hochberg MC, Wehren LE, Ross PD
and Wasnich RD: How useful are measures of BMD and bone turnover?
Curr Med Res Opin. 21:545–554. 2005.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Shiraki M, Yamazaki Y, Shiraki Y, Hosoi T,
Tsugawa N and Okano T: High level of serum undercarboxylated
osteocalcin in patients with incident fractures during
bisphosphonate treatment. J Bone Miner Metab. 28:578–584.
2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Okamura T, Ichikawa T, Miyaaki H, Miuma S,
Motoyoshi Y, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T,
et al: Change in tartrate-resistant acid phosphatase isoform 5b
levels, a marker of bone metabolism, in patients with chronic
hepatitis B treated with tenofovir alafenamide. Biomed Rep.
16(6)2022.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Holden RM, Morton AR, Garland JS, Pavlov
A, Day AG and Booth SL: Vitamins K and D status in stages 3-5
chronic kidney disease. Clin J Am Soc Nephrol. 5:590–597.
2010.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Niezen S, Tapper EB, Trivedi H, Lai M,
Curry MP, Mukamal KJ and Jiang ZG: Prevalence of high liver
stiffness and a screening strategy using the SODA-2B score among US
adults. Hepatol Commun. 6:898–909. 2022.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shephard DA: The 1975 declaration of
helsinki and consent. Can Med Assoc J. 115:1191–1192.
1976.PubMed/NCBI
|
|
27
|
Matsuo S, Imai E, Horio M, Yasuda Y,
Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H and Hishida A:
Collaborators developing the Japanese equation for estimated GFR.
Revised equations for estimated GFR from serum creatinine in Japan.
Am J Kidney Dis. 53:982–992. 2009.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Kim SW, Jung HW, Kim CH, Kim KI, Chin HJ
and Lee H: A new equation to estimate muscle mass from creatinine
and cystatin C. PLoS One. 11(e0148495)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Ichikawa T, Miyaaki H, Miuma S, Motoyoshi
Y, Narita S, Toda S, Takahashi Y, Honda T, Yajima H, Uehara R, et
al: Carotid intima-media thickness and small dense low-density
lipoprotein cholesterol increase after one year of treatment with
direct-acting antivirals in patients with hepatitis C virus
infection. Intern Med. 58:1209–1215. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Vallet-Pichard A, Mallet V, Nalpas B,
Verkarre V, Nalpas A, Dhalluin-Venier V, Fontaine H and Pol S:
FIB-4: An inexpensive and accurate marker of fibrosis in HCV
infection. Comparison with liver biopsy and fibrotest. Hepatology.
46:32–36. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kuwabara A, Fujii M, Kawai N, Tozawa K,
Kido S and Tanaka K: Bone is more susceptible to vitamin K
deficiency than liver in the institutionalized elderly. Asia Pac J
Clin Nutr. 20:50–55. 2011.PubMed/NCBI
|
|
32
|
Inoue T, Funatsu Y, Ohnishi M, Isogawa M,
Kawashima K, Tanaka M, Moriya K, Kawaratani H, Momoda R, Iio E, et
al: Bile acid dysmetabolism in the gut-microbiota-liver axis under
hepatitis C virus infection. Liver Int. 42:124–134. 2022.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wellhöner F, Döscher N, Woelfl F, Vital M,
Plumeier I, Kahl S, Potthoff A, Manns MP, Pieper DH, Cornberg M, et
al: Eradication of chronic HCV infection: Improvement of dysbiosis
only in patients without liver cirrhosis. Hepatology. 74:72–82.
2021.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Honda T, Ishigami M, Yamamoto K, Takeyama
T, Ito T, Ishizu Y, Kuzuya T, Nakamura M, Kawashima H, Miyahara R,
et al: Changes in the gut microbiota after hepatitis C virus
eradication. Sci Rep. 11(23568)2021.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Varsamis NA, Christou GA and Kiortsis DN:
A critical review of the effects of vitamin K on glucose and lipid
homeostasis: Its potential role in the prevention and management of
type 2 diabetes. Hormones (Athens). 20:415–422. 2021.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ho HJ, Komai M and Shirakawa H: Beneficial
effects of vitamin k status on glycemic regulation and diabetes
mellitus: A mini-review. Nutrients. 12(2485)2020.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Hayashi M, Abe K, Fujita M, Okai K,
Takahashi A and Ohira H: Association between sarcopenia and
osteoporosis in chronic liver disease. Hepatol Res. 48:893–904.
2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lin YH, Chen HC, Hsu NW, Chou P and Teng
MMH: Hand grip strength in predicting the risk of osteoporosis in
Asian adults. J Bone Miner Metab. 39:289–294. 2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Harshman SG, Fu X, Karl JP, Barger K,
Lamon-Fava S, Kuliopulos A, Greenberg AS, Smith D, Shen X and Booth
SL: Tissue concentrations of vitamin k and expression of key
enzymes of vitamin k metabolism are influenced by sex and diet but
not housing in C57Bl6 mice. J Nutr. 146:1521–1527. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Byun DW, Moon SH, Kim T, Lee HH, Park HM,
Kang Ml, Ha YC, Chung HY, Yoon BK, Kim TY, et al: Assessment of
patient-reported outcomes (PROs): Treatment satisfaction,
medication adherence, and quality of life (QoL) and the associated
factors in postmenopausal osteoporosis (PMO) patients in Korea. J
Bone Miner Metab. 37:563–572. 2019.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kanazawa I, Takeno A, Tanaka KI, Yamane Y
and Sugimoto T: Osteoporosis and vertebral fracture are associated
with deterioration of activities of daily living and quality of
life in patients with type 2 diabetes mellitus. J Bone Miner Metab.
37:503–511. 2019.PubMed/NCBI View Article : Google Scholar
|
